Epitope Switching as a Novel Escape Mechanism of HIV to CCR5 Monoclonal Antibodies

被引:5
|
作者
Jekle, Andreas [1 ]
Chhabra, Milloni [1 ]
Lochner, Adriane [1 ]
Meier, Sonja [1 ]
Chow, Eugene [1 ]
Brandt, Michael [2 ]
Sankuratri, Surya [1 ]
Cammack, Nick [1 ]
Heilek, Gabrielle [1 ]
机构
[1] Roche Palo Alto LLC, Palo Alto, CA 94304 USA
[2] Roche Diagnost GmbH, Penzberg, Germany
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; CHEMOKINE RECEPTORS; ANTIVIRAL ACTIVITY; HIGHLY POTENT; GP120; BINDING; TYPE-1; ENTRY; VIRAL ENTRY; INFECTION; INHIBITION; RESISTANCE;
D O I
10.1128/AAC.00841-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In passaging experiments, we isolated HIV strains resistant to MAb3952, a chemokine (C-C motif) receptor 5 (CCR5) monoclonal antibody (MAb) that binds to the second extracellular domain (extracellular loop 2 [ECL-2]) of CCR5. MAb3952-resistant viruses remain CCR5-tropic and are cross-resistant to a second ECL-2-specific antibody. Surprisingly, MAb3952-resistant viruses were more susceptible to RoAb13, a CCR5 antibody binding to the N terminus of CCR5. Using CCR5 receptor mutants, we show that MAb3952-resistant virus strains preferentially use the N terminus of CCR5, while the wild-type viruses preferentially use ECL-2. We propose this switch in the CCR5 binding site as a novel mechanism of HIV resistance.
引用
收藏
页码:734 / 741
页数:8
相关论文
共 50 条
  • [21] Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection
    Yost, Raymond
    Pasquale, Timothy R.
    Sahloff, Eric G.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (08) : 715 - 726
  • [22] The role of the N-terminal segment of CCR5 in HIV-I Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment
    Melikyan, Gregory B.
    Platt, Emily J.
    Kabat, David
    RETROVIROLOGY, 2007, 4
  • [23] CCR5 knockout strategies ... A way toward HIV cure?
    Scerra, S.
    Melica, G.
    Lelievre, J. -D.
    JOURNAL DES ANTI-INFECTIEUX, 2011, 13 (03) : 184 - 190
  • [24] Reduced CCR5 expression among Uganda HIV controllers
    Nyiro, Brian
    Amanya, Sharon Bright
    Bayiyana, Alice
    Wasswa, Francis
    Nabulime, Eva
    Kayongo, Alex
    Nankya, Immaculate
    Mboowa, Gerald
    Kateete, David Patrick
    Sande, Obondo James
    RETROVIROLOGY, 2023, 20 (01)
  • [25] The design and discovery of novel amide CCR5 antagonists
    Pryde, David C.
    Corless, Martin
    Fenwick, David R.
    Mason, Helen J.
    Stammen, Blanda C.
    Stephenson, Peter T.
    Ellis, David
    Bachelor, David
    Gordon, David
    Barber, Christopher G.
    Wood, Anthony
    Middleton, Donald S.
    Blakemore, David C.
    Parsons, Gemma C.
    Eastwood, Rachel
    Platts, Michelle Y.
    Statham, Keith
    Paradowski, Kerry A.
    Burt, Catherine
    Klute, Wolfgang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (04) : 1084 - 1088
  • [26] Peptide mimotopes selected with HIV-1-blocking monoclonal antibodies against CCR5 represent motifs specific for HIV-1 entry
    Koenigs, Christoph
    Pustowka, Anette
    Irving, James
    Kessel, Christoph
    Klich, Katharina
    Wegner, Valerie
    Rowley, Merrill J.
    Mackay, Ian R.
    Kreuz, Wolfhart
    Griesinger, Christian
    Dietrich, Ursula
    IMMUNOLOGY AND CELL BIOLOGY, 2007, 85 (07) : 511 - 517
  • [27] CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy
    Grande, Fedora
    Occhiuzzi, Maria Antonietta
    Rizzuti, Bruno
    Ioele, Giuseppina
    De Luca, Michele
    Tucci, Paola
    Svicher, Valentina
    Aquaro, Stefano
    Garofalo, Antonio
    MOLECULES, 2019, 24 (03)
  • [28] Susceptibility of HIV Type 2 Primary Isolates to CCR5 and CXCR4 Monoclonal Antibodies, Ligands, and Small Molecule Inhibitors
    Espirito-Santo, Maria
    Santos-Costa, Quirina
    Calado, Marta
    Dorr, Patrick
    Azevedo-Pereira, J. Miguel
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (05) : 478 - 485
  • [29] Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection
    Li, Lun
    Tian, Jin Hui
    Yang, KeHu
    Zhang, Peng
    Jia, Wen Qin
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (07):
  • [30] CCR5 antagonists and HIV-1 infection: Bases and consequences of this therapeutic approach
    Psomas, K. C.
    Corbeau, P.
    Reynes, J.
    ANTIBIOTIQUES, 2010, 12 (01): : 27 - 41